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Background: A dried root of Aristolochia tagala Cham. (ATC) is often used in Thai traditional medicine as an
antipyretic, anti-inflammatory agent, muscle relaxant, appetite-enhancing agent, and analeptic. Homnawakod, an
important herbal recipe, originally contains ATC in its formula, however, some Aristolochia species have been
reported to cause nephrotoxicity due to aristolochic acid (AA) and its derivatives, resulting in ATC removal from all
formulae. Therefore, this study investigates the chemical profiles of ATC, the original (HNK+ATC) and the present
Homnawakod Ayurved Siriraj Herbal Formulary™ (HNK), and investigates whether they could cause nephrotoxicity
or aggravate LPS-induced organ injuries in vivo.
Methods: HPLC and LC/MS were used for chemical profile study. Male Wistar rats were randomly divided into
groups in which the rats were intragastrically administered distilled water (2 groups), ATC (10 or 30 mg/kg), HNK
+ATC (540 or 1,620 mg/kg), or HNK (1,590 mg/kg) for 21 days. A positive control group was administered with
single dose 100 mg/kg standard AA-I intragastrically at day 1. Serum creatinine and urea were measured at baseline
and at 7, 14 and 21 days of the treatment. On day 22, a model of lipopolysaccharide (LPS)-induced endotoxemia
was used. One-way and two-way analyses of variance were performed and a P value of less than 0.05 was
considered to be significant.
Results: The similarity of the HPLC chromatograms of HNK+ATC and HNK could suggest that the qualities of both
formulae are nearly the same in terms of chemical profile. The amount of AA-I found in ATC is 0.24%w/w. All
experimental groups exhibited similar levels of serum urea at baseline and 7 and 14 days of the treatment. At
21 days, rats received AA exhibited a significant increase in serum urea, whereas the others did not exhibit such
toxicity. On day 22, there were no significant changes in LPS-induced renal and liver dysfunction, or LPS-induced
mean arterial pressure (MAP) reduction upon administration of ATC, HNK+ATC, HNK or AA-I.
Conclusions: These results suggest that ATC, HNK+ATC or HNK, at the animal dose equivalent to that used in
human, do not cause the acute nephrotoxicity in rats and do not aggravate LPS-induced organ injuries
even further.
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Krai-krue is a dried root of Aristolochia pierrei Lecomte
or Aristolochia tagala Cham. (ATC) in the family Aristo-
lochiaceae [1]. Krai-krue is one of the crude drugs often
used in Thai traditional medicine. It is used as an antipyr-
etic, anti-inflammatory agent, muscle relaxant, appetite-
enhancing agent, and analeptic [2]. Many important Thai
traditional medicine recipes contain krai-krue in their
formulae such as: original Homnawakod, Homintrajak,
Thartbanchob, and Ammaruekkhawatee.
Like other Aristolochia species [3], ATC contains aris-
tolochic acid (AA) and derivatives [2]. Unfortunately,
this AA and its derivatives have been reported to con-
tribute to the nephrotoxicity and carcinogenicity of some
Aristolochia species [4-7]. Aristolochic acid nephropathy
is a rapidly progressive interstitial nephropathy. It was
reported for the first time in 1992 as “Chinese herb
nephropathy” because it involved patients who con-
sumed Chinese herb products containing Aristolochia
species. This caused a controversy in using herbal
recipes containing ATC in traditional medicine.
Homnawakod is a famous Thai traditional herbal rem-
edy used in vertigo, nausea and vomiting treatment. It
has been widely used in Thailand for a long time, with
no report of undesirable symptoms [8]. The formula has
been included in the List of Herbal Medicinal Products
since 2006 by National Drug Committee of Thailand.
Homnawakod Ayurved Siriraj Herbal Formulary™ is a
mixture of sodium borate anhydrous and 55 herbs
(Table 1) available in powder and tablet dosage forms. It
should be used with caution in pregnant women and
pollen-hypersensitive patients. In 2011, the National
Drug Committee removed krai-krue from every Thai
traditional herbal recipe. Thus, Ayurved Siriraj™ has
removed ATC from its formulae since that time.
According to Thai traditional medicine theory that the
taste of drug is correlated with the pharmacological ac-
tion [9], ATC, which has a bitter, pungent and cool taste,
would act on blood and bile, and act as antipyretic and
appetite stimulator. In original Homnawakod, ATC is an
auxiliary drug which is a component that supports the
main ingredients [9], so removing ATC from the formula
may affect the balance of the recipe. Thus quality, safety
and efficacy assessments of the new formula from which
ATC was removed are needed.
The objectives of this study are i) to assess the quality
of the recipes by investigating the differences of chem-
ical pattern and the presence of AAs in ATC, the ori-
ginal Homnawakod Ayurved Siriraj Herbal Formulary™
(HNK+ATC) that contains ATC, and the present Hom-
nawakod Ayurved Siriraj Herbal Formulary™ (HNK),
and ii) to assess the safety of the formulae by investigat-
ing whether ATC, HNK+ATC or HNK causes nephro-
toxicity in rats. This is of importance in adding to thescientific knowledge about the use of the Homnawakod
formula, and providing information that can be applied
to other studies of ATC-removed traditional herbal for-
mulae in the future.
Methods
Test substances and chemicals
ATC, HNK+ATC, and HNK were prepared by Ayurved
Siriraj™ Manufacturing Unit of Herbal Medicine and
Products, Center of Applied Thai Traditional Medicine,
Faculty of Medicine Siriraj Hospital, Mahidol University,
Bangkok, Thailand (GMP certified since 2009).
All plant materials were purchased from Tai-hua-jan
drugstore and authenticated by two experienced Thai
traditional practitioners using macroscopic identification
and organoleptic techniques which based on anatomical
characteristics of the individual plant parts and color,
fracture, smell, or taste. Then the specimens were
sorted, washed and oven-dried. The cleaned dried roots
of ATC were ground into powder. For HNK+ATC and
HNK powder preparation, all components were accur-
ately weighed according to the master formula and then
ground together. The test specimens were kept in dry
place, at room temperature and protected from light
until use.
Reference substances, aristolochic acid I (A5512), aris-
tolochic acid I sodium salt (A9451) and aristolochic acid
mixture of I and II (R751669) were purchased from
Sigma (St. Louis, USA). Other reagents were methanol
(HPLC grade, Scharlau, Spain), acetic acid (analytical
grade, Merck, Germany) and Milli-Q water (from Milli-
Q water system, Millipore, France).
LC/ MS analysis
ATC, HNK+ATC and HNK powders were extracted
three times with methanol, under sonication (30 minutes
per one extraction). After being centrifuged at 4,000
rpm for 10 minutes at 4°C, supernatants were filtered
through the 0.2 μm polyvinylidenedifluoride filters. The
final concentrations of the sample solutions were 1.83
mg/ml for ATC, 100 mg/ml for HNK+ATC and 100 mg/
ml for HNK. Liquid chromatography (LC) analyses were
carried out using an ultra high performance liquid chro-
matography (UPLC) system (Acquity UPLCW, Waters,
Milford, MA, USA) equipped with a binary solvent de-
livery system, an auto sampler and a photodiode array
detector (Acquity UPLCW). The separations were per-
formed on a reverse phase column (Acquity UPLCW
HSS T3, 1.8μm, 2.1 x 50 mm, Waters, Ireland). The
mass spectrometry (MS) analyses were carried out on a
single quadrupole detector (SQD) mass spectrometer
(Waters) equipped with a Z-spray electrospray interface
(ESI). The analyses were done in positive mode, and the
data were acquired by single ion recording (SIR). The
Table 1 List of ingredients of Homnawakod Ayurved Siriraj Herbal Formulary™
Alyxia reinwardtii Blume Euphorbia antiquorum L. Pimpinella anisum L.
Amomum krervanh Pierre Foeniculum vulgare Pinus spp.
Anacyclus pyrehtrum (L.) Lagasca Glycyrrhiza glabra L. Piper chaba Hunt
Anethum graveolens L. Gymnopetalum chinense Piper ribesoides Wall., Dalbergia.
Angelica dahurica Benth. Jasminum sambac (L.) Piper sarmentosum Roxb.
Angelica sinensis (Oliv.) Diels Kaempferia galanga L. Plantago ovata Forssk.
Aquilaria crassna Lepidium sativum L. Plumbago indica L.
Aristolochia tagala Cham. Ligusticum sinense Saussurea lappa C.B.Clarke
Artemisia annua L. Maclura cochinchinensis (Lour.) Corner Sophora tomentosa L.
Atractylodes lancea Mammea siamensis Kostern. Syzygium aromaticum (L.)
Brucea javanica (L.) Merr. Mesua ferrea L. Terminalia bellirica (Gaertn.) Roxb.
Carum carvi L. Mimusops elengi L. (flower and wood) Terminalia chebula Retz.
Cinnamomum bejolghota Mollugo pentaphylla L. Tinospora crispa (L.)
Cinnamomun loureirii Nees Myristica fragrans Houtt. (mace, nutmeg and wood) Trachyspermum ammi (L.) Sprague
Coriandrum sativum L. Nelumbo nucifera Gaertn. Vetiveria zizanioides (L.) Nash ex Small
Cuminum cyminum L. Nigella sativa L. Zingiber officinale Roxb.
Cyperus rotundus L. Phyllanthus emblica L.
Dracaena loureiri Gagnep. Picrorhiza kurrooa Royle ex Benth.
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capillary voltage, 3 kV; source temperature, 130°C; cone
gas flow rate, 10 L/h; desolvation gas flow rate, 600 L/h;
and desolvation temperature, 350°C. Nitrogen gas
(>99.9% purity) was used. Cone voltage was optimized
by infusion of 1 μg/mL standard AA-I solution in
methanol. The mobile phase was 0.1% acetic acid in
Milli-Q water and methanol with a gradient program of
5 – 100% methanol in 20 minutes. The flow rate was
0.25 mL/min. The method was modified from Koh HL.,
et al., 2006 [10].
Animal care
Ninety-four male Wistar rats (180–250 g) were used in
this study. They were purchased from the National La-
boratory Animal Center, Nakorn Pathom, Thailand, were
used in this study. All animals received a standard diet
and water ad libitum, and were cared for in accordance
with the UK Home Office Guidance in the Operation of
the Animals (Scientific Procedures) Act 1986. Rats were
housed in the animal care facility at the Department of
Anatomy, Faculty of Siriraj Medicine Hospital, Mahidol
University under standard conditions. The animals were
acclimatized at least one week before the experiments.
The study protocol was reviewed and approved by Siriraj
Animal Care and Use Committee.
Animal preparation and treatments
After one week acclimatization, the rats were randomly
divided into seven groups and received daily intragastrictreatment of different compounds for 21 days and
received lipopolysaccharide (LPS) or vehicle on day 22
as following;
 ATC(10)+LPS: Rats received ATC (10 mg/kg/day)
for 21 days and LPS (6 mg/mL/kg) on day 22.
 ATC(30)+LPS: Rats received ATC (30 mg/kg/day)
for 21 days and LPS (6 mg/mL/kg) on day 22.
 HNK+ATC(540)+LPS: Rats received HNK+ATC
(540 mg/kg/day containing 10 mg/kg/day ATC) for
21 days and LPS (6 mg/mL/kg) on day 22.
 HNK+ATC(1620)+LPS: Rats received HNK+ATC
(1,620 mg/kg/day containing 30 mg/kg/day ATC) for
21 days and LPS (6 mg/mL/kg) on day 22.
 HNK(1590)+LPS: Rats received HNK (1,590 mg/kg/
day) for 21 days and LPS (6 mg/mL/kg) on day 22.
 Sham+LPS: Rats received sterile water for 21 days
and LPS (6 mg/mL/kg) on day 22.
 Sham+vehicle: Rats received sterile water for 21
days and vehicle of LPS (saline) on day 22.
The lower dose (10 mg/kg) of ATC was equivalent to
the amount of ATC in the highest dose of HNK+ATC
which was used in humans. The dose translation from
human to animal dose was based on body surface area
according to the formula as demonstrated in the litera-
ture [11].
Another group for positive control was administered
with single dose 100 mg/kg standard AA-I intragastri-
cally at day 1 and LPS (6 mg/mL/kg) on day 22. The
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shown to increase serum creatinine and urea as demon-
strated [3].
The model of lipopolysaccharide (LPS)-induced endo-
toxemia and organ injuries [12] was modified to study
the effects of AA-I, ATC, HNK+ATC and HNK on LPS-
induced organ injuries. Briefly, on day 22 all groups of
rats were anesthetized and treated intravenously with 6
mg/kg of LPS or saline. Mean arterial blood pressure
(MAP) was measured throughout the experiment by a
data acquisition system (PowerLab 8/30, Chart v6, AD
Instruments, Bangkok, Thailand).
Measurement of biochemical parameters
Blood samples were collected from tail vein for measure-
ment of serum creatinine and urea at baseline and 7, 14,
and 21 days of the treatment. On day 22, blood samples
were collected via carotid artery catheter at 6 hours after
LPS treatment for measurement of serum creatinine,
urea, and alanine transaminase (ALT). The samples were
centrifuged to separate the plasma. All plasma samples
were frozen and stored at −80°C until analyzed for bio-
chemical parameters by the standard laboratory in the
Department of Clinical Pathology, Faculty of Medicine
Siriraj Hospital.Figure 1 HPLC chromatograms and UV spectra of AA standard and h
and AA-II (b) ATC and UV spectra (c) overlaid HNK+ATC and HNK (d) overla
overlaid UV spectra of the peak at RT 14.510 in HNK and AA-I.Data analysis and statistical methods
All values described in the text and figures are expressed
as mean±SEM for N observations. Two-way analysis of
variance with Bonferroni post hoc-test was performed on
MAP data, and one-way analysis of variance with Dun-
nett's post hoc-test was performed on all other data
using GraphPad Prism version 5.02 for Windows
(GraphPad Software, www.graphpad.com); a P value of
less than 0.05 was considered to be significant.
Results
LC/ MS analysis
HPLC chromatographic fingerprint of standard mixture
of AA-I and AA-II is shown in Figure 1a. The retention
times (RT) of AA-I and AA-II are 14.485 and 13.666 re-
spectively. Compounds 1 and 2 presented in the samples
were identified by comparison of their RT and ultraviolet
(UV) spectra with those of the authentic standard. The
result shows that compound 1 in ATC (Figure 1b) was
AA-I because its peak was at RT 14.462 which was close
to that of AA-I and its UV spectrum was the same as AA-
I spectrum (Figure 1b). Although there were peaks at RT
14.493 in both HNK+ATC and HNK (Figure 1c) which
were close to those of AA-I, their UV spectra were differ-
ent from AA-I spectrum (Figure 1d, 1e), therefore theerbal samples. HPLC chromatograms of (a) standard mixture of AA-I
id UV spectra of the peak at RT 14.510 in HNK+ATC and AA-I and (e)
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ingly, the HPLC fingerprints of the two formulae were
nearly similar from which it can be seen that the height of
small peaks at RT 13.657 and 17.125 found in HNK+ATC
are slightly lower in HNK (Figure 1c). Identification of
AA-I and AA-II in samples by MS analysis was also per-
formed (Figure 2 and 3). From single ion recording at
m/z 342, there were AA-I peaks found in ATC (Figure 2b)
and HNK+ATC (Figure 2c), but not in HNK (Figure 2d).
AA-II peak was found only in ATC (Figure 3b). The quan-
titation of AA-I in ATC was done by LC analysis. The cali-
bration curve of AA-I done by six concentrations of
standard AA-I (2–25 mg/ml) showed an accurate linearity
(R2 = 0.999623). The amount of AA-I found in ATC
sample was 0.24 %w/w.Effect of ATC, HNK+ATC, or HNK on renal function
There was no significant difference in serum urea
(Figure 4a) or serum creatinine (Figure 4b) in groups
treated with ATC, HNK+ATC, or HNK, when compared
to vehicle-treated rats, either at baseline, or at the sev-
enth, fourteenth, or twenty-first day of the treatment. At
day 21 of the experiment, rats received AA-I exhibited a
significant increase in serum urea but not serum creatin-
ine, when compared to vehicle-treated rats.Figure 2 Total ion chromatograms of AA-I standard and herbal samp
(b) ATC (c) HNK+ATC and (d) HNK.Effect of ATC, HNK+ATC, or HNK on renal dysfunction
induced by LPS
Rats that received LPS exhibited a significant increase in
serum urea (Figure 5a), and serum creatinine (Figure 5b),
indicating renal dysfunction. Treatment of rats with
intragastric ATC, HNK+ATC, HNK or intravenous AA-I
did not aggravate further injury caused by LPS.Effect of ATC, HNK+ATC, or HNK on abnormal liver
function induced by LPS
Rats that received LPS exhibited a significant increase in
serum ALT (Figure 6), indicating liver injury. Treatment of
rats with intragastric ATC, HNK+ATC, HNK or intraven-
ous AA-I did not aggravate further injury caused by LPS.Effect of ATC, HNK+ATC, or HNK on the decrease in mean
arterial blood pressure caused by LPS
Overall, there was no significant difference in MAP be-
tween groups at baseline (Time = 0 min) (Figure 7).
Intravenous administered LPS produced a significant de-
crease in MAP 1 h after the LPS administration (Time =
80 min) (Figure 5). Intragastric administration of ATC,
HNK+ATC, HNK or intravenous AA-I did not cause
further reduction in MAP (Figure 7).les at m/z 342. Total ion chromatograms at m/z 342 of (a) AA-I
Figure 3 Total ion chromatograms of AA-II standard and herbal samples at m/z 312. Total ion chromatograms at m/z 312 of (a) AA-II (b)
ATC (c) HNK+ATC and (d) HNK.
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Some Aristolochia species have been reported to cause
nephrotoxicity and carcinogenicity due to AA and its deri-
vatives [2,4-7]. A case of unexplained nephropathy was
reported after two months ingestion of AA-containing
Aristolochia mollissemae in a patient with long-standing
Crohn's disease and recently diagnosed carcinoma of the
colon [13]. This case contributed to the withdrawal of the
AA-related herbs by the local health authority in Hong
Kong [13]. Traditional medicine in Thailand has also used
Aristolochia species in our herbal recipes. Specifically, in
the current study, a dried root of ATC, namely Krai-krue,
has been used in many herbal recipes such as Homnawa-
kod, which has been included in the List of Herbal Medi-
cinal Products since 2006 by the National Drug
Committee of Thailand. In 2011, however, the National
Drug Committee has removed krai-krue from every Thai
traditional herbal recipe. Thus, Ayurved Siriraj™ has
removed ATC from its formulae since last year, although
it is still questionable whether the formulae really cause
toxicity. More importantly, removing ATC from the for-
mula may affect the balance of the recipe. Thus quality,
safety and efficacy assessments of the new ATC-removed
formula are needed.
For the quality assessment, HPLC chromatograms of
ATC, HNK+ATC and HNK were analyzed. Although
there was a peak in HNK+ATC and HNK at the RT
close to the RT of AA-I, their UV spectra were differentfrom AA-I spectrum. This finding reveals that the peak
is not AA-I; however, it can be the result of the coelu-
tion of AA-I and another compound or more [14]. Tak-
ing into account this finding in which the interested
peak was presented in both HNK+ATC and HNK, not
in ATC, together with the finding that AA-I was clearly
identified in ATC, it is most likely that the coelution
occurs from the ingredients in HNK. The absence of
AA-I and AA-II in the HPLC chromatograms of HNK
+ATC and HNK indicates the limitation of LC/PDA for
analyzing poly-herbal formula containing numerous
ingredients. The MS may be a preferable technique.
Nevertheless, there is a published method for analyzing
traditional Chinese medicinal prescriptions that contain
up to 17 ingredients with LC/PDA [15]. To prevent in-
consistency in the ingredients quality, HNK+ATC and
HNK were produced from the same batch of raw materi-
als with the same procedure and the similarity of the
chromatograms of both formulae suggests that their
qualities are nearly the same. This indicates that the
small portion of ATC, at only 1.83 %w/w, in HNK+ATC
has only a slight effect on the overall chemical profile.
The MS analysis gave ion [M+H]+ at m/z 342 and m/z
312 for AA-I and AA-II, respectively. This is in agreement
with the previous study [10,16]. LC/MS analysis shows
that AA-I was presented clearly in ATC and HNK+ATC,
while the peak of AA-II was found only in ATC but was
too small to quantify. Therefore, the quantitation of AA-I
Figure 4 Effect of ATC, HNK+ATC, or HNK on renal function. Serum urea (a) and serum creatinine (b) were measured before and 7, 14 and
21 days after the treatment . Sham, N = 14; ATC(10), N = 10; ATC(30), N = 13; HNK+ATC(540), N = 13; HNK+ATC(1620), N = 11; HNK(1590), N = 13;
and AA-I(100), N = 9).
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due to the complexity of the HNK+ATC, the amount of
AA-I could be quantified only in the ATC sample as 0.24
%w/w, and the amount of AA-I in the formulae was
obtained from calculation. The rats in the HNK(1590)
group did not receive AA-I. The rats in the ATC(10) and
HNK+ATC(540) groups received AA-I 0.024 mg/kg/day.
Finally, the ATC(30) and HNK+ATC(1620) groups
received AA-I 0.072 mg/kg/day.
Furthermore, we demonstrate here that HNK+ATC,
HNK, or ATC itself does not cause nephrotoxicity in
rats after daily intragastric administration for at least 21
days, whereas standard AA-I significantly increases
serum urea at the twenty-first day of the experiment. A
previous study was conducted with 4 g of dried stem of
Aristolochia manshuriensis (which contained 4 mg of
AA) administered daily for 5 days in 170 g female
Wistar rats. The study showed the decrease in renal
function within the first day after oral administrationof the herb or 4 mg AA (23.53 mg/kg/day) [5]. In
contrast, another study used 7 mg/kg/day of AA, sub-
cutaneously injected once daily for 35 days. The serum
creatinine levels at 10 and 35 days of the study were
non-significantly increased compared with those of
controls. The various study designs make the compari-
son among the studies difficult. The differences be-
tween our findings and the findings from previous
literature may be attributed to the amount, route of
administration and duration of AA-I that the rats
received, together with the differences in the species of
the herb and the herbal parts used. In the present
study, the herb in the formulae is the dried root of
Aristolochia tagala Cham. and, as stated above, the
doses of AA-I were only 0.024 or 0.072 mg/kg/day.
These amounts, which have already included a half-log
scale higher dose, are much smaller than the reported
toxic doses of AA-I in other literature, which range
from 0.154 to 231 mg/kg in various study designs in
Figure 5 Effect of ATC, HNK+ATC, or HNK on renal dysfunction induced by LPS. Serum urea (a), and serum creatinine (b), were measured
on day 22 of the experiment at 6 hours after LPS treatment. Sham+vehicle, N = 5; Sham+LPS, N = 9, ATC(10)+LPS, N = 8; ATC(30)+LPS, N = 11;
HNK+ATC(540)+LPS, N = 9; HNK+ATC(1620)+LPS, N = 7; HNK(1590)+LPS, N = 11; and AA-I(100)+LPS, N = 9).
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able reason why the formulae tested in the present
study do not cause nephrotoxicity.
In addition, we demonstrate for the first time that
ATC, HNK+ATC, HNK or AA-I did not aggravate intra-
venous LPS-induced increases of serum urea, creatinine,
and ALT. The same observation also occurs for the re-
duction in MAP at 1 h after administration of LPS,
which was not aggravated by ATC, HNK+ATC, HNK or
AA-I. Although AA-I increased the level of serum ureaat day 21 of the experiment, the injury was approxi-
mately 10% only. Here, LPS caused a two-fold increase
of the level, and may mask the small effect of AA-I.
However, it can be concluded that none of the treatment
groups aggravate the renal and liver injuries and
hypotensive effect caused by LPS.
Since the lower dose (10 mg/kg) of ATC used in this
study was equivalent to the amount of ATC in the high-
est dose of HNK+ATC, which was used in humans, it is
likely that the amount of AA-I human subjects received
Figure 6 Effect of ATC, HNK+ATC, or HNK on abnormal liver function induced by LPS. Serum ALT was measured on day 22 of the
experiment at 6 hours after LPS treatment. Sham+vehicle, N = 5; Sham+LPS, N = 9, ATC(10)+LPS, N = 8; ATC(30)+LPS, N = 11; HNK+ATC(540)+LPS,
N = 9; HNK+ATC(1620)+LPS, N = 7; HNK(1590)+LPS, N = 11; and AA-I(100)+LPS, N = 9).
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accord with the fact that no adverse effect of this for-
mula has been reported despite the fact that it has been
used in Thai traditional medicine for a long time [8]. It
should be noted that the duration of treatment in this
study is 21 days which covers the duration of treatment
(1–3 weeks) for most indications in human use. How-
ever, this study may not be applicable to the human
exposed to the formula for longer than 21 days, such asFigure 7 Effect of ATC, HNK+ATC, or HNK on the decrease in MAP ca
LPS experiment. Sham+vehicle, N = 5; Sham+LPS, N = 11, ATC(10)+LPS, N =
HNK+ATC(1620)+LPS, N = 8; HNK(1590), N = 11; and AA-I(100)+LPS, N = 8).in the use of this formula at a lower dose as a nutrient
supplement. Nevertheless, Aristolochia species was
reported to be nephrotoxic and was announced by the
WHO to be carcinogenic in 2002 [9], so it was prohib-
ited to be used in many countries worldwide. Therefore,
AA-I analysis of any herbal formula is necessary in order
to avoid the consumption of AA. Although removal of
AA-containing herbs from the formulae is necessary,
any modification should be carefully studied in order toused by LPS. Mean arterial pressure was measured throughout the
9; ATC(30)+LPS, N = 11; HNK+ATC(540)+LPS, N = 10;
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the study of the quality and safety of herbal formula
modification.
Conclusions
Herein, we demonstrate that both original and modified
Homnawakod Ayurved Siriraj Herbal Formulary™, at the
dose equivalent to that used in humans, do not cause
acute nephrotoxicity or aggravate LPS-induced organ in-
juries in rats. Although the present Homnawakod
Ayurved Siriraj Herbal Formulary™ seems to be safe, and
should be used instead of the original one because it is
free from AA-I, the efficacy study of the modified for-
mula should be further investigated and compared to
the original one in order to confirm that the modifica-
tion does not change the efficacy of the formula.
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